Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Conduit Pharmaceuticals ( (CDT) ) has shared an announcement.
On May 5, 2025, Conduit Pharmaceuticals Inc. held a special meeting of stockholders where a quorum was achieved with proxies representing over one-third of the company’s common stock. During the meeting, stockholders approved amendments to the company’s Certificate of Incorporation to allow for reverse stock splits at ratios determined by the board of directors. This decision could potentially impact the company’s stock structure and market perception.
More about Conduit Pharmaceuticals
Average Trading Volume: 5,766,367
Technical Sentiment Signal: Sell
Current Market Cap: $6.09M
Learn more about CDT stock on TipRanks’ Stock Analysis page.